S. Doisneau-Sixou, P. Cestac, S. Chouini, A. D. Hamilton, S. M. Sebti, M. Poirot, P. Balaguer, J.-C. Faye, and G. Favre.
Contrasting effects of prenyltransferase inhibitors on estrogen-dependent cell cycle progression and estrogen receptor-mediated transcriptional activity in MCF-7 cells.
Endocrynology 2003, 144(3), 989-998.
DOI: 10.1210/en.2002-220726
S. C. E. Bolick, T. H. Landowski, D. Boulware, M. M. Oshiro, J. Ohkanda, A. D. Hamilton, S. M. Sebti, and W. S. Dalton.
The farnesyltransferase inhibitor, FTI-277, inhibits growth and induces apoptosis in drug-resistant myeloma tumor cells.
Leukemia 2003, 17(2), 451-457.
DOI: 10.1038/sj.leu.2402832
J. T. Ernst, J. Becerril, H. S. Park, and A. D. Hamilton.
Design and application of an α-helix mimetic scaffold based on a novel oligoamide foldamer strategy: Antagonism of the Bak BH3/Bcl-xL complex.
Angewandte Chemie: International Edition 2003, 42(5), 535-539.
DOI: 10.1002/anie.200390154
G. Wang and A. D. Hamilton.
Low molecular weight organogelators for water.
Chemical Communications 2003, (3), 310-311.
DOI: 10.1039/B205733F
L. A. Estroff, L. Leiserowitz, L. Addadi, S. Weiner, and A. D. Hamilton.
Characterization of an organic hydrogel: A cryo-transmission electron microscopy and x-ray diffraction study.
Advanced Materials 2003, 15(1), 38-42.
DOI: 10.1002/adma.200390004
K. Choi and A. D. Hamilton.
Fluoresence sensing of anions.
In J. L. Atwood and J. W. Steed, editors, Encyclopedia of Supramolecular Chemistry, page 0000. Marcel Dekker, 2003.
K. Choi and A. D. Hamilton.
Macrocyclic anion receptors based on directed hydrogen bonding interactions.
Coordination Chemistry Reviews 2003, 240(1-2), 101-110.
DOI: 10.1016/S0010-8545(02)00305-3
A. J. Wilson, K. Groves, R. Jain, H. S. Park, and A. D. Hamilton.
Directed denaturation: Room temperature unfolding of cytochrome c by a metalloporphyrin dimer.
Journal of the American Chemical Society 2003, 125(15), 4420-4421.
DOI: 10.1021/ja028574m
V. K. Potluri and A. D. Hamilton.
Isophthalic acid derived organogelators.
Journal of Supramolecular Chemistry 2003, 2(1-3), 321-326.
DOI: 10.1016/S1472-7862(03)00088-1
A. Sachpatzidis, B. K. Benton, J. Manfredi, H. Wang, A. D. Hamilton, H. Dohlman, and E. Lolis.
Identification of allosteric peptide antagonists of CXCR4.
Journal of Biological Chemistry 2003, 278(2), 896-907.
DOI: 10.1074/jbc.M204667200
V. K. Potluri, A. D. Hamilton, C. F. Karnikas, S. E. Bane, J. Xu, E. J. Beckman, and R. M. Enick.
The high CO2 solubility of per-acetylated α-, β-, and γ-cyclodextrin.
Fluid Phase Equilibria 2003, 211(2), 211-217.
DOI: 10.1016/S0378-3812(03)00206-1
K. Choi and A. D. Hamilton.
Rigid macrocyclic triamides as anion receptors: Anion dependent binding stoichiometries and 1H chemical shift changes.
Journal of the American Chemical Society 2003, 125(34), 10241-10249.
DOI: 10.1021/ja034563x
J. Ohkanda, M. A. Blaskovich, S. M. Sebti, and A. D. Hamilton.
The development of protein farnesyltransferase inhibitors as signaling-based anticancer agents.
Progress in Cell Cycle Research 2003, 5, 211-217.
T. Aya and A. D. Hamilton.
Tetrabiphenylporphyrin-based receptors for protein surfaces show sub-nanomolar affinity and enhance unfolding.
Bioorganic and Medicinal Chemistry Letters 2003, 13(16), 2651-2654.
DOI: 10.1016/S0960-894X(03)00551-1
Z. Zhang, Y. Wang, L. E. Lantry, E. Kastens, G. Liu, A. D. Hamilton, S. M. Sebti, N. E. Kohl, R. A. Lubet, and M. You.
Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice and transgenic mice with a dominant negative p53 and/or heterozygous deletion of Ink4a/Arf.
Oncogene 2003, 22(40), 6257-6265.
DOI: 10.1038/sj.onc.1206630
K. Zhu, A. D. Hamilton, and S. M. Sebti.
Farnesyltransferase inhibitors as anti-cancer agents: Current status.
Current Opinion in Investigational Drugs 2003, 4(12), 1428-1435.
B. B. Bordier, J. Ohkanda, P. Liu, S. Y. Lee, F. H. Salazar, P. L. Marion, K. Ohashi, L. Meuse, M. A. Kay, S. M. Sebti, A. D. Hamilton, and J. S. Glenn.
In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.
Journal of Clinical Investigation 2003, 112(3), 407-414.
DOI: 10.1172/JCI17704
L. A. Estroff, J. S. Huang, and A. D. Hamilton.
Fiber formation in water by a mono-urea dicarboxylic acid.
Chemical Communications 2003, 24, 2958-2959.
DOI: 10.1039/B306351H
M. Forsberg, R. Blomgran, M. Lerm, E. Sarndahl, S. M. Sebti, A. D. Hamilton, O. Stendahl, and L. Zheng.
Differential effects of invasion by and phagocytosis of Salmonella typhimurium on apoptosis in human macrophages: potential role of Rho-GTPases and Akt.
Journal of Leukocyte Biology 2003, 74(4), 620-629.
DOI: 10.1189/jlb.1202586
A. Mazzocca, S. Giusti, A. D. Hamilton, S. M. Sebti, P. Pantaleo, and V. Carloni.
Growth inhibition by the farnesyltransferase inhibitor FTI-277 involves Bcl-2 expression and defective association with Raf-1 in liver cancer cell lines.
Molecular Pharmacology 2003, 63(1), 159-166.
DOI: 10.1124/mol.63.1.159
J. Sun, J. Ohkanda, D. Coppola, H. Yin, M. Kothare, B. Busiglio, A. D. Hamilton, and S. M. Sebti.
Geranylgeranyltransferase I inhibitor, GGTI-2154, induces breast carcinoma apoptosis and tumor regression in H-Ras transgenic mice.
Cancer Research 2003, 63(24), 8922-8929.
F. Buckner, K. Yokoyama, J. Lockman, K. Aikenhead, J. Ohkanda, M. Sadilek, S. M. Sebti, W. Van Voorhis, A. D. Hamilton, and M. Gelb.
A class of sterol 14-demethylase inhibitors as anti-Trypanosoma cruzi agents.
Proceedings of the National Academy of Science 2003, 100(25), 15149-15153.
DOI: 10.1073/pnas.2535442100